Michael C. O'Donovan

Michael C. O'Donovan

Top Cited Scholar 2023
Auto-generated profile, based on publicly available information

Michael C. O'Donovan

Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, UK

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2013 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
E(European Alzheimer'S Disease Initiative (Eadi)
European Alzheimer'S Disease Initiative (Eadi)
JLJean-Charles Lambert
Jean-Charles Lambert
G(Genetic And Environmental Risk In Alzheimer'S Disease (Gerad)
Genetic And Environmental Risk In Alzheimer'S Disease (Gerad)
A(Alzheimer's Disease Genetic Consortium (ADGC)
Alzheimer's Disease Genetic Consortium (ADGC)
C(Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE)
Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE)
PAPhilippe Amouyel
Philippe Amouyel

28 February 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
BKBrian W. Kunkle
Brian W. Kunkle
T(The European Alzheimer’s Disease Initiative (Eadi)
The European Alzheimer’s Disease Initiative (Eadi)
BGBenjamin Grenier-Boley
Benjamin Grenier-Boley
RSRebecca Sims
Rebecca Sims
JBJoshua C. Bis
Joshua C. Bis
MPMargaret A. Pericak-Vance
Margaret A. Pericak-Vance

8 April 2022 in Nature
Verified
Journal Article
Closed access
PDF file
VTVassily Trubetskoy
Vassily Trubetskoy
APAntonio F. Pardiñas
Antonio F. Pardiñas
TQTing Qi
Ting Qi
GPGeorgia Panagiotaropoulou
Georgia Panagiotaropoulou
SASwapnil Awasthi
Swapnil Awasthi
SCSchizophrenia Working Group of the Psychiatric Genomics Consortium
Schizophrenia Working Group of the Psychiatric Genomics Consortium

6 September 2009 in Nature Genetics
Verified
Journal Article
Open access
PDF file
DHDenise Harold
Denise Harold
RARichard Abraham
Richard Abraham
PHPaul Hollingworth
Paul Hollingworth
RSRebecca Sims
Rebecca Sims
AGAmy Gerrish
Amy Gerrish
JWJulie Williams
Julie Williams
Julie Williams and colleagues report a genome-wide association study for Alzheimer's disease. They identify variants at the CLU and PICALM loci associated with susceptibility to late-onset Alzheimer's disease. We undertook a two-stage genome-wide association study (GWAS) of Alzheimer's disease (AD) involving over 16,000 individuals, the most powerful AD GWAS to date. In stage 1 (3,941 cases and 7,848 controls), we replicated the established association with the apolipoprotein E (APOE) locus (most significant SNP, rs2075650, P = 1.8 × 10−157) and observed genome-wide significant association with SNPs at two loci not previously associated with the disease: at the CLU (also known as APOJ) gene (rs11136000, P = 1.4 × 10−9) and 5′ to the PICALM gene (rs3851179, P = 1.9 × 10−8). These associations were replicated in stage 2 (2,023 cases and 2,340 controls), producing compelling evidence for association with Alzheimer's disease in the combined dataset (rs11136000, P = 8.5 × 10−10, odds ratio = 0.86; rs3851179, P = 1.3 × 10−9, odds ratio = 0.86).

3 April 2011 in Nature Genetics
Verified
Journal Article
Open access
PDF file
PHPaul Hollingworth
Paul Hollingworth
DHDenise Harold
Denise Harold
RSRebecca Sims
Rebecca Sims
AGAmy Gerrish
Amy Gerrish
JLJean-Charles Lambert
Jean-Charles Lambert
JWJulie Williams
Julie Williams
Julie Williams, Michael Owen and colleagues report staged follow-up and meta-analyses of genome-wide association studies for Alzheimer's disease from the GERAD+ consortium. They identify common variants at ABCA7 and MS4A6A/MS4A4E associated with Alzheimer's disease and support for several additional susceptibility loci. We sought to identify new susceptibility loci for Alzheimer's disease through a staged association study (GERAD+) and by testing suggestive loci reported by the Alzheimer's Disease Genetic Consortium (ADGC) in a companion paper. We undertook a combined analysis of four genome-wide association datasets (stage 1) and identified ten newly associated variants with P ≤ 1 × 10−5. We tested these variants for association in an independent sample (stage 2). Three SNPs at two loci replicated and showed evidence for association in a further sample (stage 3). Meta-analyses of all data provided compelling evidence that ABCA7 (rs3764650, meta P = 4.5 × 10−17; including ADGC data, meta P = 5.0 × 10−21) and the MS4A gene cluster (rs610932, meta P = 1.8 × 10−14; including ADGC data, meta P = 1.2 × 10−16) are new Alzheimer's disease susceptibility loci. We also found independent evidence for association for three loci reported by the ADGC, which, when combined, showed genome-wide significance: CD2AP (GERAD+, P = 8.0 × 10−4; including ADGC data, meta P = 8.6 × 10−9), CD33 (GERAD+, P = 2.2 × 10−4; including ADGC data, meta P = 1.6 × 10−9) and EPHA1 (GERAD+, P = 3.4 × 10−4; including ADGC data, meta P = 6.0 × 10−10).

26 February 2018 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
APAntonio F. Pardiñas
Antonio F. Pardiñas
PHPeter Holmans
Peter Holmans
APAndrew J. Pocklington
Andrew J. Pocklington
VEValentina Escott-Price
Valentina Escott-Price
SRStephan Ripke
Stephan Ripke
JWJames T. R. Walters
James T. R. Walters